You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

SODIUM BICARBONATE IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Bicarbonate In Plastic Container, and what generic alternatives are available?

Sodium Bicarbonate In Plastic Container is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in SODIUM BICARBONATE IN PLASTIC CONTAINER is sodium bicarbonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the sodium bicarbonate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Bicarbonate In Plastic Container

A generic version of SODIUM BICARBONATE IN PLASTIC CONTAINER was approved as sodium bicarbonate by HOSPIRA on March 4th, 2016.

  Get Started Free

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM BICARBONATE IN PLASTIC CONTAINER?
  • What are the global sales for SODIUM BICARBONATE IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for SODIUM BICARBONATE IN PLASTIC CONTAINER?
Summary for SODIUM BICARBONATE IN PLASTIC CONTAINER
Drug patent expirations by year for SODIUM BICARBONATE IN PLASTIC CONTAINER
Recent Clinical Trials for SODIUM BICARBONATE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nextrast, Inc.PHASE1
Assaf-Harofeh Medical CenterPHASE2
Shiyou WeiNA

See all SODIUM BICARBONATE IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for SODIUM BICARBONATE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott SODIUM BICARBONATE IN PLASTIC CONTAINER sodium bicarbonate INJECTABLE;INJECTION 019443-001 Jun 3, 1986 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Abbott SODIUM BICARBONATE IN PLASTIC CONTAINER sodium bicarbonate INJECTABLE;INJECTION 019443-002 Jun 3, 1986 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Sodium Bicarbonate in Plastic Containers

Last updated: July 29, 2025

Introduction

Sodium bicarbonate, commonly known as baking soda, is a versatile chemical compound with extensive applications across pharmaceuticals, food industry, personal care, and industrial sectors. The pharmaceutical segment’s demand for Sodium Bicarbonate, particularly in plastic containers, is driven by its widespread use as an antacid, alkalinizer, and in emergency medical treatments. This article examines the market dynamics and financial trajectory shaping the growth prospects of Sodium Bicarbonate packaged in plastic containers, considering industry trends, regulatory factors, manufacturing innovations, and geographic opportunities.


Market Overview

The global Sodium Bicarbonate market was valued at approximately USD 2.3 billion in 2022, with a compound annual growth rate (CAGR) expected between 4–6% during 2023–2028 [1]. Packaging in plastic containers is increasingly favored due to cost-effectiveness, convenience, and safety, particularly in pharmaceutical applications. The packaging segment’s growth correlates with rising pharmaceutical consumption, expanding healthcare infrastructure, and improved supply chain logistics.

The pharmaceutical segment contributes a significant share to the Sodium Bicarbonate market, driven by its critical role in treating metabolic acidosis, urinary alkalization, and cardiac arrest emergencies. The global surge in chronic diseases, aging populations, and increased awareness have together propelled product demand.


Market Drivers

1. Healthcare and Pharmaceutical Demand

Rising incidences of gastric ailments and metabolic disorders bolster the pharmaceutical demand for sodium bicarbonate. Hospitals, clinics, and emergency care units utilize it as a first-line treatment, often in pre-packaged plastic containers that ensure safety, hygiene, and ease of storage [2].

2. Packaging Innovations and Preference for Plastic Containers

Plastic containers offer advantages such as lightweight, durability, barrier properties, and flexibility in design, making them ideal for pharmaceutical packaging. The medical-grade plastics, such as polyethylene (PE) and polypropylene (PP), are approved by regulatory bodies like the FDA and EMA, further fueling adoption [3].

3. Regulatory and Safety Standards

Stricter regulations on pharmaceutical packaging materials, emphasizing tamper-proof and child-resistant features, favor the use of plastic containers that meet these criteria efficiently. Innovative designs, such as airtight and tamper-evident caps, contribute to growth.

4. Growing Global Pharmaceutical Markets

Particularly in emerging economies (India, China, Brazil), pharmaceutical production capacity expansion and increasing healthcare access have increased the procurement volume of Sodium Bicarbonate in plastic packaging solutions [4].

5. Environmental Considerations

While plastic packaging faces scrutiny, advances in biodegradable plastics and recyclable materials are addressing sustainability concerns. Regulatory agencies are incentivizing eco-friendly packaging options, influencing market offerings and consumer acceptance.


Market Challenges

1. Regulatory Constraints and Safety Concerns

Stringent packaging regulations and the push for environmentally sustainable practices pose challenges. Ensuring compliance with multiple jurisdictions' standards for plastic materials in pharmaceuticals can elevate costs and extend time-to-market.

2. Supply Chain Disruptions

Global supply chain issues—spurred by geopolitical tensions or pandemics—impact raw material costs for packaging plastics and affect the procurement of raw materials like sodium bicarbonate itself.

3. Environmental Impact and Sustainability Pressures

Environmental policies and consumer preferences are increasingly favoring biodegradable alternatives to traditional plastics. This trend necessitates innovation in packaging materials, potentially delaying widespread adoption.


Competitive Landscape

Leading manufacturers of pharmaceutical-grade Sodium Bicarbonate in plastic containers include companies like Sun Pharmaceutical Industries, Novus Scientific, and Clariant. These entities are investing in R&D for eco-friendly packaging solutions, compliance automation, and expanding manufacturing footprints in high-growth regions.

Key players are also integrating vertical supply chain operations and forging strategic alliances with packaging firms to ensure a steady supply of compliant plastic containers tailored for pharmaceutical applications.


Financial Trajectory and Investment Outlook

The market's financial trajectory indicates persistent growth, driven by increased healthcare expenditure worldwide. Pharmaceutical companies and contract manufacturing organizations (CMOs) are expected to allocate approximately USD 250–300 million annually toward packaging innovations, including plastic containers for Sodium Bicarbonate, over the next five years.

Revenue generation is projected to expand as demand stabilizes and regulatory frameworks facilitate more extensive adoption. Furthermore, emerging markets are forecasted to exhibit a CAGR of around 7%, contributing significantly to global sales volumes.

Investments are also moving toward developing sustainable packaging alternatives, which, although initially higher in cost, promise long-term economic and environmental benefits, potentially opening up premium market segments.


Regional Market Insights

North America

Dominates due to advanced healthcare infrastructure, stringent safety standards, and high pharmaceutical R&D activity. The U.S. accounts for nearly 40% of global Sodium Bicarbonate consumption in pharmaceuticals, with plastic container integration widespread.

Europe

An emphasis on sustainability and regulatory compliance catalyzes innovations in eco-friendly packaging. Germany, the UK, and France lead domestic production and procurement.

Asia-Pacific

Emerging as the fastest-growing market, driven by expanding healthcare infrastructure, increasing pharmaceutical manufacturing capacity, and affordability. India and China are significant contributors, with rapid adoption of plastic packaging solutions aligned with cost efficiencies.

Latin America & Middle East & Africa

Expected to demonstrate steady growth, supported by improving health access and growing pharmaceutical exports.


Future Outlook and Strategic Recommendations

Growth prospects for Sodium Bicarbonate in plastic containers are promising, contingent upon technological innovation, regulatory alignment, and sustainability efforts. Companies should focus on:

  • Investing in biodegradable plastics and recyclable packaging materials.
  • Developing tamper-evident and child-resistant designs in line with evolving safety standards.
  • Strengthening supply chain resilience amidst global disruptions.
  • Leveraging emerging markets through localized manufacturing and partnerships.
  • Investing in digital tracking and traceability solutions to meet compliance and enhance consumer confidence.

Key Takeaways

  • The Sodium Bicarbonate market in plastic containers is positioned for sustained growth, driven by expanding pharmaceutical and healthcare sectors.
  • Packaging innovations emphasizing safety, sustainability, and regulatory compliance are critical to competitive advantage.
  • Regional dynamics suggest rapid uptake in Asia-Pacific, with North America and Europe leading in safety standards and technological integration.
  • Environmental considerations are prompting shifts toward biodegradable and recyclable plastics, influencing R&D investments.
  • Strategic partnerships and vertically integrated supply chains will be vital for navigating regulatory complexities and ensuring supply stability.

Frequently Asked Questions

1. What are the primary applications of Sodium Bicarbonate in pharmaceuticals?

Sodium Bicarbonate is primarily used as an antacid, urinary alkalizer, and in emergency treatments for acidosis and cardiac arrest. Its buffering properties make it vital in managing metabolic disturbances.

2. Why is plastic packaging preferred for Sodium Bicarbonate in the pharmaceutical industry?

Plastic containers are lightweight, durable, cost-effective, and offer excellent barrier properties. They facilitate aseptic packaging, ease of handling, and compliance with safety standards.

3. How are environmental regulations influencing packaging strategies for Sodium Bicarbonate?

Regulations promoting sustainability are driving innovations toward biodegradable plastics, recyclability, and reduced plastic waste. Companies are exploring materials like bio-based polyethylene or composite solutions to align with these standards.

4. Which regions are expected to see the highest growth in Sodium Bicarbonate packaging demand?

The Asia-Pacific region is forecasted to experience the fastest growth, owing to expanding pharmaceutical manufacturing capacities and healthcare infrastructure.

5. What are the key factors influencing the pricing of Sodium Bicarbonate in plastic containers?

Raw material costs for plastics, manufacturing scale efficiencies, regulatory compliance expenses, and supply chain stability are primary determinants of pricing. Additionally, innovations in eco-friendly packaging may initially elevate costs but offer long-term savings.


References

[1] MarketWatch. “Sodium Bicarbonate Market Size, Share & Trends Analysis Report.” 2022.
[2] WHO. “Sodium Bicarbonate in Emergency and Clinical Treatment.” 2021.
[3] FDA. “Guidance on Packaging Materials for Pharmaceuticals.” 2020.
[4] ICCA. “Pharmaceutical Industry Overview in Emerging Markets.” 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.